In addition, muscle growth inhibitor (myostain) and growth differentiation factor 15 (GDF-15) expressions were detected elevating in COPD (Patel et al., 2016; Zhang et al., 2022), thereby promoting muscle atrophy and inhibiting muscle expression of miR-1. Here, GDF15 is linked to chronic obstructive pulmonary disease.